%0 Journal Article
%T Clinical significance of miRNA - 106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy
%A Changyu Sun
%A Limeng Zhang
%A Ye Tian
%A Yuan Pan
%J Archive of "Cancer Biology & Medicine".
%D 2018
%R 10.20892/j.issn.2095-3941.2017.0182
%X Research has demonstrated that microRNA (miR)-106a is related to cisplatin resistance. We investigated the expression of miR-106a in the serum of patients with non-small cell lung cancer (NSCLC) and their sensitivity to chemotherapy by cisplatin combined with gemcitabine
%K MiRNA-106a
%K NSCLC
%K cisplatin
%K gemcitabine
%K chemotherapy resistant
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994549/